119 filings
Page 5 of 6
8-K
7uc ypugr
31 Jan 18
Sage Therapeutics Announces Positive Results from Placebo-Controlled Trial in a Model of
12:00am
8-K
sh2 olhenk
8 Jan 18
Other Events
12:00am
8-K
arrh8 pgajs97
7 Dec 17
Sage Therapeutics Reports PositiveTop-line Results from Phase 2 Placebo-Controlled Trial ofSAGE-217 in Major Depressive Disorder
12:00am
8-K
1s2a1x wh70
17 Nov 17
Sage Therapeutics Announces Closing of $345 Million Public Offering of Common
12:00am
8-K
qhwp0yhm
15 Nov 17
Sage Therapeutics Announces Proposed Public Offering of Common Stock
12:00am
8-K
vz3xo6cf6079
9 Nov 17
Sage Therapeutics Announces Brexanolone Achieves Primary Endpoints in Both Phase 3 Clinical Trials in Postpartum Depression
12:00am
8-K
lb8lov0j769oaj
8 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
ffgf7kv v8
7 Nov 17
Sage Therapeutics Announces Third Quarter 2017 Financial Results and Provides Pipeline Update
12:00am
8-K
l3rpbq2 gi
12 Sep 17
Sage Therapeutics ReportsTop-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus
12:00am
8-K
cfj80nof4l2p8os835
3 Aug 17
Sage Therapeutics Announces Second Quarter 2017 Financial Results and Provides Pipeline Update
12:00am
8-K
2z81k 80mbiv42n
8 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
rxa llqam4yjwy
9 May 17
Sage Therapeutics Announces First Quarter 2017 Financial Results and Provides Pipeline Update
12:00am
8-K
nre2jbf7bcdki
9 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
s1jk3mi9k0569p865ike
23 Feb 17
Sage Therapeutics Announces Fourth Quarter and Full Year 2016 Financial
12:00am
8-K
ulsadbu1 508
3 Nov 16
Sage Therapeutics Announces Third Quarter 2016 Financial Results and Provides
12:00am
8-K
4by7bgly 1s7w1wmnpf
15 Sep 16
Other Events
12:00am
8-K
orfop7e9zu0 fg
9 Sep 16
Sage Therapeutics Announces Proposed Public Offering of Common Stock
12:00am
8-K
4qpds1f5g vpa9h3098
9 Aug 16
Sage Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
12:00am
8-K
fl1e6b cp
21 Jul 16
Sage Appoints Geno Germano to Company’s Board of Directors
12:00am
8-K
6dm5d33iyf3wb
13 Jul 16
Sage Reports Positive Top-line Results Including Demonstration of 30-Day Durability from
12:00am